Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM

Excessive hepatic glucose output is an important factor in the fasting hyperglycemia of non-insulindependent diabetes mellitus (NIDDM). To determine the relative contributions of gluconeogenesis and glycogenolysis in a quantitative manner, we applied a new isotopic approach, using infusions of [6-3H]glucose and [2-14C]acetate to trace overall hepatic glucose output and phosphoenolpyruvate gluconeogenesis in 14 postabsorptive NIDDM subjects and in 9 nondiabetic volunteers of similar age and weight. Overall hepatic glucose output was increased nearly twofold in the NIDDM subjects (22.7 ± 1.0 vs. 12.0 ± 0.6 μmol · kg−1 · min−1 in the nondiabetic volunteers, P < .001); phosphoenolpyruvate gluconeogenesis was increased more than threefold in the NIDDM subjects (12.7 ± 1.4 vs. 3.6 ± 0.4 μmol kg−1 min−1 in the nondiabetic subjects, P < .001) and was accompanied by increased plasma lactate, alanine, and glucagon concentrations (all P < .05). The increased phosphoenolpyruvate gluconeogenesis accounted for 89 ± 6% of the increase in overall hepatic glucose output in the NIDDM subjects and was significantly correlated with the fasting plasma glucose concentrations (r = .67, P < .01). Glycogenolysis, calculated as the difference between overall hepatic glucose output and phosphoenolpyruvate gluconeogenesis, was not significantly different in the NIDDM subjects (9.9 ± 0.06 μmol · kg−1 · min−1) and the nondiabetic volunteers (8.4 ± 0.3 μmol kg−1 · min−1). We conclude that increased gluconeogenesis is the predominant mechanism responsible for increased hepatic glucose output in NIDDM.

[1]  W. A. Müller,et al.  Studies of pancreatic alpha cell function in normal and diabetic subjects. , 1970, The Journal of clinical investigation.

[2]  Z. A. Trapeznikova.  On the Interaction of , 1959 .

[3]  B. Landau,et al.  Pathways of acetoacetate's formation in liver and kidney. , 1982, The Journal of biological chemistry.

[4]  R. Sherwin,et al.  Carbohydrate homeostasis, liver and diabetes. , 1976, Progress in liver diseases.

[5]  S. Weinhouse,et al.  Quantitative Estimation of the Cori Cycle in the Human , 1963 .

[6]  L. Mandarino,et al.  Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. , 1988, Metabolism: clinical and experimental.

[7]  J. Keilson,et al.  Cori cycle activity in man. , 1969, The Journal of clinical investigation.

[8]  G. Hetényi,et al.  Correction for metabolic exchange in the calculation of the rate of gluconeogenesis in rats. , 1983, Biochemical medicine.

[9]  J. Moorhouse,et al.  Circulating Alanine Disposal in Diabetes Mellitus , 1978, Diabetes.

[10]  E. Hultman,et al.  Liver glycogen in man--the effect of total starvation or a carbohydrate-poor diet followed by carbohydrate refeeding. , 1973, Scandinavian journal of clinical and laboratory investigation.

[11]  J. A. Scarlett,et al.  Insulin Treatment Reverses the Insulin Resistance of Type II Diabetes Mellitus , 1982, Diabetes Care.

[12]  J. A. Scarlett,et al.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. , 1981, The Journal of clinical investigation.

[13]  G. Sonnenberg,et al.  Sampling of arterialized heated-hand venous blood as a noninvasive technique for the study of ketone body kinetics in man. , 1982, Metabolism: clinical and experimental.

[14]  E. Hultman,et al.  Factors influencing carbohydrate metabolism in man. , 1975, Nutrition and metabolism.

[15]  E H STRISOWER,et al.  Conversion of fatty acids to carbohydrate; application of isotopes to this problem and role of the Krebs cycle as a synthetic pathway. , 1957, Physiological reviews.

[16]  S. Lillioja,et al.  Increased Resting Metabolic Rates in Obese Subjects with Non-insulin-dependent Diabetes Mellitus and the Effect of Sulfonylurea Therapy , 1986, Diabetes.

[17]  P. Donahue,et al.  Similar Dose Responsiveness of Hepatic Glycogenolysis and Gluconeogenesis to Glucagon In Vivo , 1987, Diabetes.

[18]  G. Shulman,et al.  Differential Time Course of Glucagon's Effect on Glycogenolysis and Gluconeogenesis in the Conscious Dog , 1981, Diabetes.

[19]  M. Haymond,et al.  Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man. , 1983, The Journal of clinical investigation.

[20]  W. C. Owen,et al.  Alanine and gluconeogenesis in man: effect of ethanol. , 1972, The Journal of clinical endocrinology and metabolism.

[21]  J. Chiasson,et al.  Differential Sensitivity of Glycogenolysis and Gluconeogenesis to Insulin Infusions in Dogs , 1976, Diabetes.

[22]  D. Porte,et al.  The Interaction of Diabetes and Obesity on the Regulation of Fat Mobilization in Man , 1969, Diabetes.

[23]  R. Hill,et al.  ANALYTICAL PROCEDURES USING A COMBINED COMBUSTION-DIFFUSION VESSEL. SIMPLE WET-COMBUSTION METHOD SUITABLE FOR ROUTINE CARBON-14 ANALYSES , 1954 .

[24]  R. DeFronzo,et al.  Mechanism of improvement in glucose metabolism after chronic glyburide therapy. , 1984, Diabetes.

[25]  E. Ferrannini.  The theoretical bases of indirect calorimetry: a review. , 1988, Metabolism: clinical and experimental.

[26]  J. Halter,et al.  The Effect of Chronic Sulfonylurea Therapy on Hepatic Glucose Production in Non-insulin-dependent Diabetes , 1982, Diabetes.

[27]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.

[28]  G. Brechtel,et al.  Effects of Fasting on Plasma Glucose and Prolonged Tracer Measurement of Hepatic Glucose Output in NIDDM , 1987, Diabetes.

[29]  A. Consoli,et al.  Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man. , 1987, The Journal of clinical investigation.

[30]  R. Kreisberg,et al.  Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Katz,et al.  Determination of gluconeogenesis in vivo with 14C-labeled substrates. , 1985, The American journal of physiology.

[32]  D. Kipnis,et al.  A microfluorometric enzymatic assay for the determination of alanine and pyruvate in plasma and tissues. , 1972, The Journal of laboratory and clinical medicine.

[33]  J. Olefsky,et al.  Effects of Weight Loss on Mechanisms of Hyperglycemia in Obese Non-Insulin-Dependent Diabetes Mellitus , 1986, Diabetes.

[34]  S. Lillioja,et al.  Increased Rate of Cori Cycle in Obese Subjects With NIDDM and Effect of Weight Reduction , 1988, Diabetes.

[35]  A. Baron,et al.  Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics , 1987, Diabetes.

[36]  R. Rognstad,et al.  An enzymic-chemical degradation of glucose. , 1968, Analytical biochemistry.

[37]  J. A. Scarlett,et al.  The Acute and Chronic Effects of Sulfonylurea Therapy in Type II Diabetic Subjects , 1984, Diabetes.

[38]  R. Rizza,et al.  Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. , 1986, The Journal of clinical investigation.